Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine

Completed

Conditions studied: Platelet Aggregation, Bleeding

In brief

The objective is to describe and quantify levels of platelet reactivity in three different cohorts of patients taking thienopyridine: patients who report nuisance bleeding, patients who report alarming bleeding, and patients who report no nuisance or alarming bleeding. The investigators hypothesize that patients with nuisance or alarming bleeding events on maintenance thienopyridine therapy will have lower levels of platelet reactivity than patients without nuisance or alarming bleeding on thienopyridine therapy.

Key facts

Study ID
NCT01152229
Run by
Medstar Health Research Institute
People needed
300
Starts
2010-04-01
Expected to finish
2011-07-01
Last updated by the study team
2011-08-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.